Drug Shortage Report for SANDOZ ESOMEPRAZOLE

Last updated on 2020-08-24 History
Report ID 99066
Drug Identification Number 02460939
Brand name SANDOZ ESOMEPRAZOLE
Common or Proper name ESOMEPRAZOLE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ESOMEPRAZOLE
Strength(s) 40MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-11-11
Estimated end date 2020-08-07
Actual end date 2020-08-03
Shortage status Resolved
Updated date 2020-08-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2019-11-18 French Compare
v1 2019-11-18 English Compare

Showing 21 to 22 of 22